Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
78
TMDX Quote, Financials, Valuation and Earnings
Last price:
$145.31
Seasonality move
:
29.19%
Day range:
$128.00 - $135.41
52-week range:
$62.07 - $156.00
Dividend yield:
0%
P/E ratio:
27.71x
P/S ratio:
9.01x
P/B ratio:
9.72x
Volume:
825.1K
Avg. volume:
799.9K
1-year change:
82.44%
Market cap:
$4.6B
Revenue:
$605.5M
EPS (TTM):
$4.86
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
$155.3M | $0.37 | 21.06% | -6.01% | $157.55 |
|
CNMD
CONMED Corp.
|
$366.9M | $1.32 | -2.76% | 322.31% | $47.40 |
|
ELMD
Electromed, Inc.
|
$18M | -- | 11.79% | -- | $37.00 |
|
ESMC
Escalon Medical Corp.
|
-- | -- | -- | -- | -- |
|
IRIX
IRIDEX Corp.
|
$14.7M | -$0.02 | 10.68% | -50.4% | $3.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
$134.57 | $157.55 | $4.6B | 27.71x | $0.00 | 0% | 9.01x |
|
CNMD
CONMED Corp.
|
$45.87 | $47.40 | $1.4B | 30.28x | $0.20 | 1.74% | 1.04x |
|
ELMD
Electromed, Inc.
|
$24.07 | $37.00 | $199.2M | 23.43x | $0.00 | 0% | 3.06x |
|
ESMC
Escalon Medical Corp.
|
$0.24 | -- | $1.8M | 154.45x | $0.00 | 0% | 0.21x |
|
IRIX
IRIDEX Corp.
|
$1.46 | $3.00 | $25.1M | -- | $0.00 | 0% | 0.48x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
52.33% | 1.795 | 12.49% | 6.41x |
|
CNMD
CONMED Corp.
|
46.21% | 0.814 | 70.58% | 0.94x |
|
ELMD
Electromed, Inc.
|
-- | 0.920 | -- | 4.40x |
|
ESMC
Escalon Medical Corp.
|
31.63% | 2.696 | 43.39% | 1.03x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.622 | 18.81% | 1.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TMDX
TransMedics Group, Inc.
|
$93.4M | $21.3M | 22.46% | 57.97% | 13.23% | $19M |
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ELMD
Electromed, Inc.
|
$14.8M | $3.6M | 20.33% | 20.35% | 19.16% | $2.4M |
|
ESMC
Escalon Medical Corp.
|
$1.6M | $98.7K | -10.13% | -12.94% | 2.75% | -$517.4K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
TransMedics Group, Inc. vs. Competitors
-
Which has Higher Returns TMDX or CNMD?
CONMED Corp. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of 4.48%. TransMedics Group, Inc.'s return on equity of 57.97% beat CONMED Corp.'s return on equity of 4.72%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M CNMDCONMED Corp.57.12% $0.54 $1.9B -
What do Analysts Say About TMDX or CNMD?
TransMedics Group, Inc. has a consensus price target of $157.55, signalling upside risk potential of 17.07%. On the other hand CONMED Corp. has an analysts' consensus of $47.40 which suggests that it could grow by 3.34%. Given that TransMedics Group, Inc. has higher upside potential than CONMED Corp., analysts believe TransMedics Group, Inc. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 3 0 CNMDCONMED Corp.0 5 0 -
Is TMDX or CNMD More Risky?
TransMedics Group, Inc. has a beta of 2.059, which suggesting that the stock is 105.878% more volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.967, suggesting its less volatile than the S&P 500 by 3.283%.
-
Which is a Better Dividend Stock TMDX or CNMD?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 1.74% to investors and pays a quarterly dividend of $0.20 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TMDX or CNMD?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are smaller than CONMED Corp. quarterly revenues of $373.5M. TransMedics Group, Inc.'s net income of $105.4M is higher than CONMED Corp.'s net income of $16.7M. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 27.71x while CONMED Corp.'s PE ratio is 30.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 9.01x versus 1.04x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.9.01x 27.71x $160.8M $105.4M CNMDCONMED Corp.1.04x 30.28x $373.5M $16.7M
-
Which has Higher Returns TMDX or ELMD?
Electromed, Inc. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of 14.61%. TransMedics Group, Inc.'s return on equity of 57.97% beat Electromed, Inc.'s return on equity of 20.35%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M ELMDElectromed, Inc.78.42% $0.32 $45.4M -
What do Analysts Say About TMDX or ELMD?
TransMedics Group, Inc. has a consensus price target of $157.55, signalling upside risk potential of 17.07%. On the other hand Electromed, Inc. has an analysts' consensus of $37.00 which suggests that it could grow by 53.72%. Given that Electromed, Inc. has higher upside potential than TransMedics Group, Inc., analysts believe Electromed, Inc. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 3 0 ELMDElectromed, Inc.3 0 0 -
Is TMDX or ELMD More Risky?
TransMedics Group, Inc. has a beta of 2.059, which suggesting that the stock is 105.878% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.264, suggesting its less volatile than the S&P 500 by 73.581%.
-
Which is a Better Dividend Stock TMDX or ELMD?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or ELMD?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than Electromed, Inc. quarterly revenues of $18.9M. TransMedics Group, Inc.'s net income of $105.4M is higher than Electromed, Inc.'s net income of $2.8M. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 27.71x while Electromed, Inc.'s PE ratio is 23.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 9.01x versus 3.06x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.9.01x 27.71x $160.8M $105.4M ELMDElectromed, Inc.3.06x 23.43x $18.9M $2.8M
-
Which has Higher Returns TMDX or ESMC?
Escalon Medical Corp. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of 2.72%. TransMedics Group, Inc.'s return on equity of 57.97% beat Escalon Medical Corp.'s return on equity of -12.94%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M ESMCEscalon Medical Corp.43.33% $0.01 $2.6M -
What do Analysts Say About TMDX or ESMC?
TransMedics Group, Inc. has a consensus price target of $157.55, signalling upside risk potential of 17.07%. On the other hand Escalon Medical Corp. has an analysts' consensus of -- which suggests that it could grow by 4900%. Given that Escalon Medical Corp. has higher upside potential than TransMedics Group, Inc., analysts believe Escalon Medical Corp. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 3 0 ESMCEscalon Medical Corp.0 0 0 -
Is TMDX or ESMC More Risky?
TransMedics Group, Inc. has a beta of 2.059, which suggesting that the stock is 105.878% more volatile than S&P 500. In comparison Escalon Medical Corp. has a beta of 0.389, suggesting its less volatile than the S&P 500 by 61.1%.
-
Which is a Better Dividend Stock TMDX or ESMC?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Escalon Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. Escalon Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or ESMC?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than Escalon Medical Corp. quarterly revenues of $3.6M. TransMedics Group, Inc.'s net income of $105.4M is higher than Escalon Medical Corp.'s net income of $97.7K. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 27.71x while Escalon Medical Corp.'s PE ratio is 154.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 9.01x versus 0.21x for Escalon Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.9.01x 27.71x $160.8M $105.4M ESMCEscalon Medical Corp.0.21x 154.45x $3.6M $97.7K
-
Which has Higher Returns TMDX or IRIX?
IRIDEX Corp. has a net margin of 65.55% compared to TransMedics Group, Inc.'s net margin of -12.6%. TransMedics Group, Inc.'s return on equity of 57.97% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital TMDXTransMedics Group, Inc.58.11% $2.58 $992.4M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About TMDX or IRIX?
TransMedics Group, Inc. has a consensus price target of $157.55, signalling upside risk potential of 17.07%. On the other hand IRIDEX Corp. has an analysts' consensus of $3.00 which suggests that it could grow by 105.48%. Given that IRIDEX Corp. has higher upside potential than TransMedics Group, Inc., analysts believe IRIDEX Corp. is more attractive than TransMedics Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMDXTransMedics Group, Inc.7 3 0 IRIXIRIDEX Corp.1 0 0 -
Is TMDX or IRIX More Risky?
TransMedics Group, Inc. has a beta of 2.059, which suggesting that the stock is 105.878% more volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.705, suggesting its less volatile than the S&P 500 by 29.514%.
-
Which is a Better Dividend Stock TMDX or IRIX?
TransMedics Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TransMedics Group, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMDX or IRIX?
TransMedics Group, Inc. quarterly revenues are $160.8M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. TransMedics Group, Inc.'s net income of $105.4M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, TransMedics Group, Inc.'s price-to-earnings ratio is 27.71x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TransMedics Group, Inc. is 9.01x versus 0.48x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMDXTransMedics Group, Inc.9.01x 27.71x $160.8M $105.4M IRIXIRIDEX Corp.0.48x -- $12.5M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
